tiprankstipranks
Analyst Profile
Followed by 32 other investors
.
Joshua Raskin

Joshua Raskin

Nephron
Wall Street Analyst
Ranked #1,017 out of 8,050 Analysts on TipRanks (#1,792 out of 21,576 overall experts)

Success Rate

62%
125 out of 202 Profitable Transactions

Average Return

8.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
If you copied Joshua Raskin's ratings since 2013 and opened each position for the duration of 1 Year:
61.88% of your transactions would have been profitable with an average return of 8.2%

Stock Rating Distribution

409Ratings
45.97% Hold
44.50% Buy
9.54% Sell
Distribution of Joshua Raskin's ratings

Additional Information

Main Sector:Healthcare
Geo Coverage:
United StatesUS Market

Best Rating

Stock:
Centene
(CNC)
Rating Type:Buy
Dates:Jan 05, 2017 - Jan 05, 2018
Gain:75.30%
The most profitable rating made by Joshua Raskin

Joshua Raskin's Stock Coverage

Company Name
Date
Position
Action
Price Target
Success Rate
Avg Return
No. of Ratings
VHS
Vanguard Health Systems
Mar 25, 2013
Buy
Reiterated
100%
+35.10%
1
HNT
Health Net
Aug 05, 2015
Sell
Reiterated
10%
-30.74%
12
TMH
Team Health Holdings
Aug 03, 2016
Buy
Reiterated
80%
+13.66%
10
Surgery Partners
Aug 10, 2016
Hold
Reiterated
$20.00
(-43.10% Downside)
0.00%
2
SCAI
Surgical Care
Nov 02, 2016
Buy
Reiterated
100%
+22.50%
4
MGLN
Magellan Health
Nov 23, 2016
Sell
Reiterated
50%
-5.85%
17
Welltower
Jan 05, 2017
Buy
Reiterated
$73.00
(-9.45% Downside)
53%
+7.91%
16
Tenet Healthcare
Jan 05, 2017
Buy
Reiterated
$24.00
(-62.23% Downside)
8%
-28.14%
16
Elevance Health
Feb 02, 2017
Hold
Reiterated
$169.00
(-65.41% Downside)
0.00%
14
Cigna
Feb 03, 2017
Hold
Reiterated
$156.00
(-46.17% Downside)
0.00%
24
List of latest recommendations made by Joshua Raskin. Click to expand and see Joshua Raskin's performance on a particular stock
Disclaimer: TipRanks collects ratings and price targets of analysts by scanning publicly available reports on financial websites and by receiving reports directly from the analysts or from our users. The information displayed and the Analyst Profile statistics might not be accurate, complete, or up to date. The analyst ratings provided are entirely at the sole responsibility of the of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings or opinions expressed on the site.
Are We Missing a Rating?
Send us the equity research you are getting and become a Power User
Learn More